Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medic

Dr. Liu is a clinical leader who brings expertise in the discovery, development, and regulatory approval of oncology therapies worldwide

Ms. Wentworth has over two decades of industry experience in... | July 18, 2022

Related Keywords

China , Beijing , Shanghai , David Liu , Pacira Biosciences , Nuvation Bio , Quality At Agenus Inc , Massachusetts Institute Of Technology , University Of Toledo , Genelabs Technologies Inc , Oncology Global Clinical Research , Global Prostate Cancer Program , Pediatric Clinical Development , Nuvation Bio Inc , University Peking School Of Medicine , Bristol Myers Squibb , Regulatory Affairs At Genzyme , Translational Research , University Of New Hampshire , Chief Medical Officer , Kerry Wentworth , Chief Regulatory , New Drug Application , Chief Regulatory Officer , Flexion Therapeutics , David Hung , Chief Executive Officer , After Bristol Myers Squibb , Global Lead Physician , Massachusetts Institute , Beijing Medical University , Peking University School , Vice President , Genelabs Technologies , Regulatory Affairs , Nuvation Bio Inc Stock Exchange , News , Information , Press Release , Liu , Us , Linical , Leader , Who , Rings , Expertise , N , The , End , Egulatory , Approval , F , Ncology , Therapies , Wentworth , Gas , Dover , Two , Ecades , Industry , Xperience Nuvb Us67080n1019 ,